RASSF1 and neuroblastoma: This was observed in one study comparing the RASSF1A methylation in serum with tumor samples revealing that RASSF1A was methylated in 17/68 (25%) in serum samples versus 64/68 (94%) in tumor samples of neuroblastoma patients [43].